Change search
ReferencesLink to record
Permanent link

Direct link
Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
Show others and affiliations
2005 (English)In: J Hypertens, ISSN 0263-6352, Vol. 23, no 7, 1425-31 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 23, no 7, 1425-31 p.
Keyword [en]
Aged, Antihypertensive Agents/*economics/therapeutic use, Atenolol/economics/therapeutic use, Clinical Trials as Topic, Cost-Benefit Analysis, Double-Blind Method, Electrocardiography, Female, Humans, Hypertension/complications/diagnosis/drug therapy/*economics, Hypertrophy; Left Ventricular/*complications/diagnosis/drug therapy/*economics, Losartan/*economics/therapeutic use, Male, Middle Aged, National Health Programs/*economics, Quality of Life, Quality-Adjusted Life Years, Randomized Controlled Trials as Topic, Risk Factors, Stroke/prevention & control, Sweden, Treatment Outcome
URN: urn:nbn:se:umu:diva-6263PubMedID: 15942467OAI: diva2:145932
Available from: 2007-12-08 Created: 2007-12-08 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Lindholm, Lars H
By organisation
Family Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 21 hits
ReferencesLink to record
Permanent link

Direct link